Filter
42
Filtered Results: 42
Text search:
Goh,
N.
S.
L.
Featured
Recommendations
7
New Publications
11
Language
Document type
No document type
23
Guidelines
10
Studies & Reports
7
Manuals
2
Countries / Regions
Nepal
11
Russia
3
Syria
2
Global
2
Middle East and North Africa
2
Yemen
2
South–East Asia Region
1
Eastern Europe and Central Asia
1
Bangladesh
1
Brazil
1
Sudan
1
South Sudan
1
Indonesia
1
India
1
Authors & Publishers
Publication Years
Category
Capacity Building
7
COVID-19
5
Guidelines
5
Drugs & Medical Equipment
2
Women & Child Health
2
Community Health
2
Studies & Reports
2
Non-communicable Diseases
2
Paediatrics
1
Buruli Ulcer
1
Cancer
1
Cancer Treatment & Resources
1
Sexual Violence
1
Pediatrics
1
Vaccine-preventable Diseases
1
Medical Devices & Equipment
1
Disabilities
1
NTDs & Others
1
Dengue
1
HIV & STI
1
Toolboxes
PPE Personel Protective Equipment
8
Medical & Community Masks
3
Preparedness, Response & Risk Communication
2
Outbreak Prevention & Control
1
Clinical Guidelines
1
Dengue
1
Training
1
Country specific documents
1
Preparedness, Response & Risk Communication
1
Traditional & Herbal Medicines
1
Mental Disorders
1
Nuclear & Chemical Hazards
1
Clinical Aspects & Diagnostics
1
Prevention & Strategies
1
Studies & Reports
1
Others
1
Clinical Aspects & Diagnosis
1
Drug resistant TB
1
Neurological Disorders
1
Mental disorders, others
1
Self-harm & Suicide
1
Neurological disorders, Others
1
Maternal and Neonatal health update: by the Nepal government, Health and population ministry, Health protection unit, Family health department, created in 2010 (English) 2067 (Nepali). Compiled together by: UNICEF, WHO, UNFPA, NHSSP, Nepal medical college hospital and other government health departm...
-Operations Directory
-Year 2010 (2067 Nepalese)
-By the Government of Nepal, Ministry of population and Health, Health service department, National health training centre.
Location: Teku, Kathmandu.
Guidelines for Therapy and Management of Renal Malignant Tumour in Indonesia
Operation and management of local health institutions to participate in the committee on capacity building.
-Instructors Guide
-By the Government of Nepal, Ministry of population and Health, Health service department, National health training centre.
Location: Teku, Kathmandu.
Created in...
Print version ISSN 1809-9823On-line version ISSN 1981-2256
Rev. bras. geriatr. gerontol. vol.19 no.2 Rio de Janeiro Mar./Apr. 2016
http://dx.doi.org/10.1590/1809-98232016019.150040
J. European Academy of Dermatology and Venereology, 4 August 2014
Effective risk communication requires the alignment of complex factors including trust between the communicator and the audience(s), audience involvement, and emotional responses to risk. Risk communication is especially challenging now as new media changes the landscape for both
communicators and...
PLOS ONE | DOI:10.1371/journal.pone.0133869 July 28, 2015, p.1-16
Применение масок в контексте COVID-19
recommended
Временные рекомендации
5 июня 2020 г
Ношение медицинской маски является одной из профилактических мер, которая может ограничить распространение ряда вирусных инф...
23 décembre 2020 Ce document résume les recommandations de l'OMS concernant l'utilisation rationnelle des équipements de protection individuelle (EPI) dans les établissements de soins de santé et les stratégies temporaires en cas de pénurie aiguë d'approvisionnement. Ce document contient ég...
interim Guidance 1 December 2020. Updated version
This document provides updated guidance on mask use in health care and community settings, and during home care for COVID-19 cases. It is intended for policy makers, public health and infection prevention and control professionals, health care manag...
Brazilian media and science communicators must understand the main characteristics of misinformation in social media about COVID-19, so that they can develop attractive, up-to-date and evidence-based content that helps to increase health literacy and counteract the spread of false information.
The availability of controlled medicines is crucial for patients requiring palliative care, pain relief and symptom management. Many individuals worldwide, especially in low- and middle-income countries, continue to experience limited access to these essential medicines. Enhancing access to controll...
ABSTRACT
More than 500 million people worldwide live with cardiovascular disease (CVD). Health systems today face fundamental challenges in delivering optimal care due to ageing populations, healthcare workforce constraints, financing, availability and affordability of CVD medicine, and service del...
Silicosis is not a new disease; the impact of silica dust on respiratory function was observed by Hippocrates in 430 B.C. and in the 16th century by Agricol. In 1713, Rammazini described silicotic nodules in post-mortems of stone cutters presenting with respiratory symptoms. In the mid-late 1800s,...
Time has seen management for Cystic Fibrosis (CF) advance drastically, most recently in the development of the disease-modifying triple combination therapy ivacaftor/tezacaftor/elexacaftor. There is currently limited evidence regarding both the global epidemiology of CF and access to this transforma...
